- Home
- CISS vs SXTP Comparison
CISS vs SXTP Comparison
Compare CISS & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- SXTP
- Stock Information
- Founded
- CISS 2022
- SXTP 2010
- Country
- CISS Greece
- SXTP United States
- Employees
- CISS N/A
- SXTP N/A
- Industry
- CISS Marine Transportation
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- CISS Consumer Discretionary
- SXTP Health Care
- Exchange
- CISS Nasdaq
- SXTP Nasdaq
- Market Cap
- CISS 3.0M
- SXTP 2.4M
- IPO Year
- CISS N/A
- SXTP 2023
- Fundamental
- Price
- CISS $0.58
- SXTP $1.84
- Analyst Decision
- CISS
- SXTP Hold
- Analyst Count
- CISS 0
- SXTP 1
- Target Price
- CISS N/A
- SXTP N/A
- AVG Volume (30 Days)
- CISS 80.0K
- SXTP 32.2K
- Earning Date
- CISS 05-27-2025
- SXTP 05-14-2025
- Dividend Yield
- CISS N/A
- SXTP N/A
- EPS Growth
- CISS N/A
- SXTP N/A
- EPS
- CISS N/A
- SXTP N/A
- Revenue
- CISS $42,296,101.00
- SXTP $681,345.00
- Revenue This Year
- CISS N/A
- SXTP $95.50
- Revenue Next Year
- CISS N/A
- SXTP $93.02
- P/E Ratio
- CISS N/A
- SXTP N/A
- Revenue Growth
- CISS 47.17
- SXTP 168.70
- 52 Week Low
- CISS $0.48
- SXTP $1.41
- 52 Week High
- CISS $13.50
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- CISS 30.12
- SXTP 41.59
- Support Level
- CISS $0.48
- SXTP $1.72
- Resistance Level
- CISS $0.74
- SXTP $1.92
- Average True Range (ATR)
- CISS 0.05
- SXTP 0.18
- MACD
- CISS 0.00
- SXTP 0.07
- Stochastic Oscillator
- CISS 37.27
- SXTP 38.30
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.